27 December 2019 | De novo mutations in EIF2B1 affecting eIF2 signaling cause neonatal/early onset diabetes and transient hepatic dysfunction | De Franco, E; Caswell, R; Johnson, M; et al. |
4 June 2018 | Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study | Bowman, P; Sulen, Å; Barbetti, F; et al. |
14 March 2018 | Are the new drugs better? Changing UK prescribing of Type 2 diabetes medications and effects on HbA1c and weight, 2010 to 2016 | Dennis, JM; Henley, WE; Weedon, MN; et al. |
3 April 2018 | Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children. | Bonifacio, E; Beyerlein, A; Hippich, M; et al. |
30 January 2018 | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic | Clissold, RL; Fulford, J; Hudson, M; et al. |
4 September 2019 | GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI | Alves, AC; De Silva, NMG; Karhunen, V; et al. |
20 February 2018 | Genetic risk scores in adult-onset type 1 diabetes - Authors' reply | Thomas, NJ; Jones, SE; Weedon, MN; et al. |
18 December 2019 | Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K ATP -channel pathways | Bowman, P; McDonald, TJ; Knight, BA; et al. |
27 November 2018 | Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity | Bowman, P; Flanagan, SE; Hattersley, AT |
18 January 2019 | Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting | Wright, CF; West, B; Tuke, M; et al. |